Affimed to Present at the SVB Leerink 9th Annual Global Healthcare Conference
February 19 2020 - 7:30AM
Heidelberg, Germany, February 19, 2020
– Affimed N.V. (Nasdaq: AFMD), a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer, today announced that its Chief
Executive Officer, Dr. Adi Hoess, will present at the SVB Leerink
9th Annual Global Healthcare Conference on Tuesday, February 25,
2020 at 10:30 a.m. Eastern Time.
A live webcast of the presentation can be
accessed under the “Investors” section of Affimed’s website at
https://www.affimed.com/investors/webcasts_cp/ and will be
available for 30 days following the event.
About Affimed N.V.
Affimed (Nasdaq: AFMD) is a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer. Affimed’s fit-for-purpose ROCK®
platform allows innate cell engagers to be designed for specific
patient populations. The Company is developing single and
combination therapies to treat hematologic and solid tumors. For
more information, please visit www.affimed.com.
Affimed Investor and Media
Contacts
Gregory Gin, Head of Investor RelationsE-Mail:
IR@affimed.com
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Sep 2023 to Sep 2024